Resources

The Bracken Group
Recent Posts

Cancer Moonshot FDA Guidelines Update

The Bracken Group

Get to Know Wil Reinus, M.D., Partner and Consultant with The Bracken Group

The Bracken Group

Get to Know Victor Miranda, M.D., Partner and Consultant with The Bracken Group

The Bracken Group

Remembering 2021, Predicting 2022

The Bracken Group

A Novel Read Methodology in Nuclear Medicine in Neuroendocrine Tumors

The Bracken Group

The Challenge in Creating Ethical Pharmaceuticals from Cannabinoids

The Bracken Group

Falgun Chokshi, M.D., Joins Bracken as Partner

The Bracken Group

Reporting on a Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-satoreotide Trizoxetan As An Imaging Agent in Gastroenteropancreatic Neuroendocrine Tumors

The Bracken Group

Get to Know Andrew Salzman, M.D., Partner and Consultant with The Bracken Group

The Bracken Group

Why Readers Vary in Interpreting Clinical Trial Images, and When to Worry About It

The Bracken Group
CONTACT US

Ask us anything.

We would be delighted to hear from you and discuss our consulting services. Please call +1 215 648 1208 to chat with us directly. Or write to us using the form provided here. We look forward to collaborating with you.